PtBio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.76M

  • Investors
  • 12

PtBio General Information

Description

Developer of a bioinformatics platform designed to manipulate and study deoxyribonucleic acid (DNA) sequences. The company's tool offers alignment, variant calling, and functional annotation to identify genes involved in target functions through extensive genome information and conducts mutational analysis to verify and confirm desired genetic mutations, enabling biotechnology and pharmaceutical companies to design and test new products, improve inherited traits, and accelerate research and development timelines.

Contact Information

Website
www.pt-bio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3-10-23 Kagamiyama
  • Higashi-Hiroshima, Hiroshima 739-0046
  • Japan
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 3-10-23 Kagamiyama
  • Higashi-Hiroshima, Hiroshima 739-0046
  • Japan

PtBio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PtBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 08-Sep-2025 $1.76M Completed Generating Revenue
8. Early Stage VC (Series A) 25-Oct-2023 Completed Generating Revenue
7. Accelerator/Incubator 12-Oct-2023 Completed Generating Revenue
6. Accelerator/Incubator 13-Sep-2023 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
4. Early Stage VC (Series B) 10-Sep-2021 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 30-Aug-2019 Completed Startup
To view PtBio’s complete valuation and funding history, request access »

PtBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class F Preferred
Class E Preferred
Class D Preferred
Class C Preferred
Class B Preferred 3,200,000 $0.000017 $0.59 $0.59 1x $0.59 14.57%
Class A Preferred 440,000 $0.000017 $0.3 $0.3 1x $0.3 2%
To view PtBio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PtBio Patents

PtBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025017235-A Method for estimating mutation introduction efficiency by genome edit tool Active 24-Jul-2023
JP-7923550-B2 Method for estimating the efficiency of mutation introduction using genome editing tools Active 24-Jul-2023
WO-2024070589-A1 Off-target risk analysis method, off-target risk analysis system, program and recording medium Inactive 30-Sep-2022
JP-7878661-B2 Off-target risk analysis method, off-target risk analysis system, program, recording medium Active 30-Sep-2022

PtBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PtBio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chugin Capital Partner Venture Capital Minority
Kewpie Corporation Minority
Tomita Pharmaceutical (Multi-line Chemicals) Corporation Minority
Kobe University Capital Venture Capital Minority
Tsuneishi Capital Partners Corporate Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

PtBio FAQs

  • When was PtBio founded?

    PtBio was founded in 2019.

  • Where is PtBio headquartered?

    PtBio is headquartered in Higashi-Hiroshima, Japan.

  • What is the size of PtBio?

    PtBio has 15 total employees.

  • What industry is PtBio in?

    PtBio’s primary industry is Biotechnology.

  • Is PtBio a private or public company?

    PtBio is a Private company.

  • What is the current valuation of PtBio?

    The current valuation of PtBio is .

  • What is PtBio’s current revenue?

    The current revenue for PtBio is .

  • How much funding has PtBio raised over time?

    PtBio has raised $5.82M.

  • Who are PtBio’s investors?

    Chugin Capital Partner, Kewpie, Tomita Pharmaceutical (Multi-line Chemicals), Kobe University Capital, and Tsuneishi Capital Partners are 5 of 12 investors who have invested in PtBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process